Abstract
This article has been corrected: Due to errors during data processing, partial duplication occurred between Figures 2c, 2e and 4b. In addition, typing errors were made within Figure 6e and Supplemental 4a. In Figure 6e, the correlation coefficient (r value) in the picture is -0.177. In the original picture, the '-' is missing. In Supplementary figure 4a, the labeling of BECN-1 and EHMT2 were reversed. The authors declare that these corrections do not change the results or conclusions of this paper. (Figure Presented).
Cite
CITATION STYLE
Park, S. E., Yi, H. J., Suh, N., Park, Y. Y., Koh, J. Y., Jeong, S. Y., … Hwang, J. J. (2019). Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB (Oncotarget (2016) 7 (39796-39808) DOI: 10.18632/oncotarget.92900). Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.27046
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.